Literature DB >> 11055988

Mechanisms of NO/cGMP-dependent vasorelaxation.

M Sausbier1, R Schubert, V Voigt, C Hirneiss, A Pfeifer, M Korth, T Kleppisch, P Ruth, F Hofmann.   

Abstract

Both cGMP-dependent and -independent mechanisms have been implicated in the regulation of vascular tone by NO. We analyzed acetylcholine (ACh)- and NO-induced relaxation in pressurized small arteries and aortic rings from wild-type (wt) and cGMP kinase I-deficient (cGKI(-/-)) mice. Low concentrations of NO and ACh decreased the spontaneous myogenic tone in wt but not in cGKI(-/-) arteries. However, contractions of cGKI(-/-) arteries and aortic rings were reduced by high concentrations (10 micromol/L) of 2-(N:, N-diethylamino)-diazenolate-2-oxide (DEA-NO). Iberiotoxin, a specific blocker of Ca(2+)-activated K(+) (BK(Ca)) channels, only partially prevented the relaxation induced by DEA-NO or ACh in pressurized vessels and aortic rings. DEA-NO increased the activity of BK(Ca) channels only in vascular smooth muscle cells isolated from wt cGKI(+/+) mice. These results suggest that low physiological concentrations of NO decrease vascular tone through activation of cGKI, whereas high concentrations of DEA-NO relax vascular smooth muscle independent of cGKI and BK(Ca). NO-stimulated, cGKI-independent relaxation was antagonized by the inhibition of soluble guanylyl cyclase or cAMP kinase (cAK). DEA-NO increased cGMP to levels that are sufficient to activate cAK. cAMP-dependent relaxation was unperturbed in cGKI(-/-) vessels. In conclusion, low concentrations of NO relax vessels by activation of cGKI, whereas in the absence of cGKI, NO can relax small and large vessels by cGMP-dependent activation of cAK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055988     DOI: 10.1161/01.res.87.9.825

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  58 in total

1.  cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.

Authors:  Jun Kotera; Kennard A Grimes; Jackie D Corbin; Sharron H Francis
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

2.  Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase.

Authors:  Michael E Wall; Sharron H Francis; Jackie D Corbin; Kennard Grimes; Robyn Richie-Jannetta; Jun Kotera; Brian A Macdonald; Rowena R Gibson; Jill Trewhella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

Review 3.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

4.  PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.

Authors:  Sergei D Rybalkin; Irina G Rybalkina; Masami Shimizu-Albergine; Xiao-Bo Tang; Joseph A Beavo
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 5.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

6.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

7.  Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Authors:  Thomas M Moon; Nathan R Tykocki; Jessica L Sheehe; Brent W Osborne; Werner Tegge; Joseph E Brayden; Wolfgang R Dostmann
Journal:  Chem Biol       Date:  2015-12-17

8.  Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.

Authors:  Ying Zhu; Jian Yao; Yiman Meng; Ayumi Kasai; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Takashi Miida; Masayuki Takeda; Masahiko Okada; Masanori Kitamura
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

9.  IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase.

Authors:  Angela Geiselhöringer; Matthias Werner; Katja Sigl; Petra Smital; René Wörner; Linda Acheo; Juliane Stieber; Pascal Weinmeister; Robert Feil; Susanne Feil; Jörg Wegener; Franz Hofmann; Jens Schlossmann
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

10.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.